Roles of Inflammasomes in Inflammatory Kidney Diseases

被引:41
|
作者
Fan, Jinjin [1 ]
Xie, Kaifeng [2 ]
Wang, Liqin [3 ]
Zheng, Nuoyan [4 ]
Yu, Xueqing [1 ]
机构
[1] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Nephrol, Guangzhou 510000, Guangdong, Peoples R China
[2] Guangdong Med Univ, Zhanjiang 524001, Guangdong, Peoples R China
[3] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Radiol, Guangzhou 510000, Guangdong, Peoples R China
[4] Sun Yat Sen Univ, Affiliated Hosp 1, Translat Med Ctr, Guangzhou 510000, Guangdong, Peoples R China
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
SYSTEMIC-LUPUS-ERYTHEMATOSUS; INHIBITING NLRP3 INFLAMMASOME; ATTENUATES MURINE LUPUS; INNATE IMMUNE DETECTION; SMOOTH-MUSCLE-CELLS; RENAL INFLAMMATION; MECHANISTIC INSIGHTS; RHEUMATOID-ARTHRITIS; DIABETIC-NEPHROPATHY; RECEPTOR ANTAGONIST;
D O I
10.1155/2019/2923072
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The immune system has a central role in eliminating detrimental factors, by frequently launching inflammatory responses towards pathogen infection and inner danger signal outbreak. Acute and chronic inflammatory responses are critical determinants for consequences of kidney diseases, in which inflammasomes were inevitably involved. Inflammasomes are closely linked to many kidney diseases such as acute kidney injury and chronic kidney diseases. Inflammasomes are macromolecules consisting of multiple proteins, and their formation initiates the cleavage of procaspase-1, resulting in the activation of gasdermin D as well as the maturation and release of interleukin-1 beta and IL-18, leading to pyroptosis. Here, we discuss the mechanism in which inflammasomes occur, as well as their roles in inflammatory kidney diseases, in order to shed light for discovering new therapeutical targets for the prevention and treatment of inflammatory kidney diseases and consequent end-stage renal disease.
引用
收藏
页数:14
相关论文
共 50 条
  • [41] Targeting inflammasomes in rheumatic diseases
    Alexander So
    Annette Ives
    Leo A. B. Joosten
    Nathalie Busso
    Nature Reviews Rheumatology, 2013, 9 : 391 - 399
  • [42] Inflammasomes and microbiomes in autoinflammatory diseases
    Lamkanfi, M.
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 : 18 - 18
  • [43] Interferons in Autoimmune and Inflammatory Diseases: Regulation and Roles
    Choubey, Divaker
    Moudgil, Kamal D.
    JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2011, 31 (12): : 857 - 865
  • [44] Update of pericytes function and their roles in kidney diseases
    Chou, Yu -Hsiang
    Pan, Szu-Yu
    Shih, Hong-Mou
    Lin, Shuei-Liong
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2024, 123 (03) : 307 - 317
  • [45] Role of Inflammasomes in Kidney Diseases via Both Canonical and Non-canonical Pathways
    Xiang, Huiling
    Zhu, Feng
    Xu, Zhifeng
    Xiong, Jing
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2020, 8
  • [46] From inflammasomes to fevers, crystals and hypertension: how basic research explains inflammatory diseases
    McDermott, Michael F.
    Tschopp, Juerg
    TRENDS IN MOLECULAR MEDICINE, 2007, 13 (09) : 381 - 388
  • [47] Editorial: The Roles of Checkpoint Inhibitors in Inflammatory Diseases
    von Knethen, Andreas
    Rodriguez-Barbosa, Jose-Ignacio
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [48] Emerging Roles of Inflammasomes in Acute Pneumonia
    Kumar, Sangeetha Ravi
    Paudel, Sagar
    Ghimire, Laxman
    Bergeron, Scott
    Cai, Shanshan
    Zemans, Rachel L.
    Downey, Gregory P.
    Jeyaseelan, Samithamby
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197 (02) : 160 - 171
  • [49] Specific inflammasomes in complex diseases
    Masters, Seth L.
    CLINICAL IMMUNOLOGY, 2013, 147 (03) : 223 - 228
  • [50] Inflammasomes in neuroinflammatory and neurodegenerative diseases
    Voet, Sofie
    Srinivasan, Sahana
    Lamkanfi, Mohamed
    van Loo, Geert
    EMBO MOLECULAR MEDICINE, 2019, 11 (06)